ArticleQuantitative imaging in medicine and surgery2024
A fully convolutional neural network for the quantification of mitral regurgitation in echocardiography.
Article in Quantitative imaging in medicine and surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Accuracy of machine learning models for mitral regurgitation severity assessment: A systematic review and meta-analysis.International journal of cardiology. Cardiovascular risk and prevention · 2026Review
- Technological Innovations and Research Frontiers in Interventional Therapy for Mitral Regurgitation.Reviews in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mitral regurgitation (MR) is the most common form of valvular heart disease (VHD), and the accurate assessment of MR severity is critical for clinical management. However, the quantitative assessment of MR is intricate and time-consuming, posing challenges for physicians in ensuring the precision of the results. Thus, our objective was to create an automated and reproducible artificial intelligence (AI) system. This study aimed to assist physicians in grading MR severity using color Doppler echocardiograms through the implementation of a fully convolutional neural network (FCN). Methods: A retrospective cohort was established comprising 433 patients diagnosed with MR based on clinical criteria. Following screening, 269 patients met the inclusion criteria for the study. In total, 4,104 frames from apical 4-chamber view color Doppler flow images constituted the training and validation set, while 1,060 frames comprised the test set. Using the FCN, the MR flow convergence region was captured and segmented. The algorithm also estimated the parameter radius, which was employed to compute the effective regurgitant orifice area (EROA) and regurgitant volume (RV) based on the proximal isovelocity surface area. These measurements were subsequently graded following the 2017 American Society of Echocardiography (ASE) guidelines. The segmentation and grading performance of the model were assessed. Additionally, the diagnostic performance of the AI model was compared to that of ultrasound physicians with varying years of experience. Results: In groups I, II, III, and IV, the rates of correctly identifying the radius were 0.56, 0.83, 0.86, and 0.89, while the grading accuracy was 0.95, 0.89, 0.88, and 0.91, respectively. Regarding patients with MR of different etiologies, the grading accuracy for the functional MR and degenerative MR groups was 0.82 and 0.90, respectively. Using Carpentier classification of MR as the criterion, the accuracy for groups I, II, and IIIb was 0.80, 0.90, and 0.83, respectively. Conclusions: The model showed commendable performance, streamlining the clinical diagnostic process and enhancing the precision and stability of quantitative MR assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.